Respiratory syncytial virus infection in older adults: an under-recognized problem
- PMID: 25851217
- DOI: 10.1007/s40266-015-0258-9
Respiratory syncytial virus infection in older adults: an under-recognized problem
Abstract
Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense RNA virus and member of the Paramyxoviridae family of the genus Pneumovirus that was first reported as a major pathogen in pediatric populations. However, since its discovery, RSV has not infrequently been detected in adults. Reinfection occurs throughout life, with more severe disease occurring in older adults, immunocompromised patients, and those with underlying cardiopulmonary disease. Initially described as the cause of nursing home outbreaks of respiratory disease, there is a now significant body of literature describing the clinical importance of RSV in older adults in a multitude of settings including long-term care, adult daycares, and in community-dwelling adults. Moreover, recent reports from China and other countries emphasize that RSV is a global pathogen that will become increasingly important in developed nations with aging populations. Annual attack rates in the USA range from 2 to 10% in community-dwelling older adults and 5-10% in older adults living in congregate settings. Population-based calculations of the proportion of acute respiratory illnesses attributable to RSV estimate that 11,000 elderly persons die annually in the USA of illnesses related to RSV infection. Clinical manifestations of RSV infections are similar to that of other viral respiratory pathogens and include cough, nasal congestion, rhinorrhea, sore throat, and dyspnea. Lower respiratory tract disease is common and may result in respiratory failure (8-13%) or death (2-5%). Recent advances in molecular diagnostics have made it possible to rapidly identify RSV infection using nucleic acid amplification tests, although clinicians will need to suspect the diagnosis when viral activity is high. At the present time, treatment is supportive. Effective antiviral agents for the treatment and vaccines for prevention of RSV remain a significant unmet medical need in the older adult population.
Similar articles
-
Respiratory syncytial virus infections in adults: a narrative review.Lancet Respir Med. 2024 Oct;12(10):822-836. doi: 10.1016/S2213-2600(24)00255-8. Epub 2024 Sep 9. Lancet Respir Med. 2024. PMID: 39265602 Review.
-
Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment.Clin Infect Dis. 2005 Aug 1;41(3):311-7. doi: 10.1086/431591. Epub 2005 Jun 29. Clin Infect Dis. 2005. PMID: 16007526
-
Respiratory syncytial virus infection in adults.Clin Microbiol Rev. 2000 Jul;13(3):371-84. doi: 10.1128/CMR.13.3.371. Clin Microbiol Rev. 2000. PMID: 10885982 Free PMC article. Review.
-
Respiratory syncytial virus infection in elderly adults.Med Mal Infect. 2018 Sep;48(6):377-382. doi: 10.1016/j.medmal.2018.01.008. Epub 2018 Mar 13. Med Mal Infect. 2018. PMID: 29548714 Review.
-
Clinical and epidemiologic features of respiratory syncytial virus.Curr Top Microbiol Immunol. 2013;372:39-57. doi: 10.1007/978-3-642-38919-1_2. Curr Top Microbiol Immunol. 2013. PMID: 24362683
Cited by
-
Influenza and respiratory syncytial virus infections in the oldest-old continent.Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2085-2090. doi: 10.1007/s10096-020-03959-9. Epub 2020 Jun 27. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32594325 Free PMC article.
-
Rate of Hospitalizations and Mortality of Respiratory Syncytial Virus Infection Compared to Influenza in Older People: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2022 Dec 7;10(12):2092. doi: 10.3390/vaccines10122092. Vaccines (Basel). 2022. PMID: 36560501 Free PMC article. Review.
-
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.Front Immunol. 2023 Sep 27;14:1250198. doi: 10.3389/fimmu.2023.1250198. eCollection 2023. Front Immunol. 2023. PMID: 37841265 Free PMC article. Review.
-
Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015.Sci Rep. 2017 Jul 14;7(1):5501. doi: 10.1038/s41598-017-04824-0. Sci Rep. 2017. PMID: 28710393 Free PMC article.
-
The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.PLoS One. 2017 Aug 10;12(8):e0182321. doi: 10.1371/journal.pone.0182321. eCollection 2017. PLoS One. 2017. PMID: 28797053 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical